Not Yet Recruiting
A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
NCT07393321
- Conditions
- Breast Diseases, Breast Neoplasms, HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer, +4 more
- Locations
-
Not specified